Sage Journals: Discover world-class research

Retricted access

Research article

First published 2022-12

Safety and feasibility of outpatient high-dose cytarabine and intermediate-dose cytarabine for consolidation therapy in acute myeloid leukemia

Wenhui Li, Katherine Richter, Jamie Lee [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2020-9

Acute cerebellar toxicity induced by high dose of cytarabine (HiDAC): A case report

Hamid Rahmani, Mojan Radmehr, Molouk Hadjibabaie [...]

Journal of Oncology Pharmacy Practice

Retricted access

Other

First published 1997-06

Pancreatitis and fatal ARDS following high-dose cytarabine induction for acute myelogenous leukemia

Eric T Wittbrodt, Victor M Aviles

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2016

Severe palmar-plantar erythrodysesthesia and aplasia in an adult undergoing re-induction treatment with high-dose cytarabine for acute myelogenous leukemia: a possible drug interaction between posaconazole and cytarabine

Saeed K Alzghari, Susan E Seago, Christian T Cable [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2016-12

Successful use of high-dose cytarabine in a patient with acute myeloid leukemia and severe hepatic dysfunction

Jacob A Barker, Bernard L Marini, Dale Bixby [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2019-6

Acute Hepatotoxicity After High-Dose Cytarabine for the Treatment of Relapsed Acute Myeloid Leukemia: A Case Report

Samuel H. Fu, Alexander H. Flannery, Melissa L. Thompson Bastin

Hospital Pharmacy

Retricted access

Research article

First published 1987-1

Cytarabine-Induced Cerebellar Syndrome: Case Report and Literature Review

Robert K. Sylvester, Alan J. Fisher, Michael Lobell

Annals of Pharmacotherapy

Retricted access

Other

First published 2003-2

High-Dose Cytarabine for Consolidation and Relapse Therapy in Acute Myelogenous Leukemia

Paula Doulaveris, Dominic A. Solimando, J. Aubrey Waddell

Hospital Pharmacy

Retricted access

Other

First published 2003-1

High-Dose Cytarabine (HIDAC) plus Daunorubicin for Remission Induction of Acute Myelogenous Leukemia

J. Aubrey Waddell, Paula Doulaveris, Dominic A. Solimando

Hospital Pharmacy

Retricted access

Research article

First published 2020-05

90 Y-Daclizumab (Anti-CD25),High-Dose Carmustine,Etoposide,Cytarabine,and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma

Kevin C. Conlon, Claude Sportes, Martin W. Brechbiel [...]

Cancer Biotherapy and Radiopharmaceuticals

Search results